286 related articles for article (PubMed ID: 30070607)
21. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
[TBL] [Abstract][Full Text] [Related]
22. Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells.
Luz MA; Marques MJ; Santo Neto H
Braz J Med Biol Res; 2002 Jun; 35(6):691-5. PubMed ID: 12045834
[TBL] [Abstract][Full Text] [Related]
23. Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients.
Nakayama Y; Nara N; Kawakita Y; Takeshima Y; Arakawa M; Katoh M; Morita S; Iwatsuki K; Tanaka K; Okamoto S; Kitamura T; Seki N; Matsuda R; Matsuo M; Saito K; Hara T
Am J Pathol; 2004 May; 164(5):1773-82. PubMed ID: 15111323
[TBL] [Abstract][Full Text] [Related]
24. The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice.
Stupka N; Gregorevic P; Plant DR; Lynch GS
Acta Neuropathol; 2004 Apr; 107(4):299-310. PubMed ID: 14727129
[TBL] [Abstract][Full Text] [Related]
25. Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling.
Turk R; Sterrenburg E; de Meijer EJ; van Ommen GJ; den Dunnen JT; 't Hoen PA
BMC Genomics; 2005 Jul; 6():98. PubMed ID: 16011810
[TBL] [Abstract][Full Text] [Related]
26. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
[TBL] [Abstract][Full Text] [Related]
27. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
[TBL] [Abstract][Full Text] [Related]
28. Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy.
Wehling-Henricks M; Li Z; Lindsey C; Wang Y; Welc SS; Ramos JN; Khanlou N; Kuro-O M; Tidball JG
Hum Mol Genet; 2016 Jun; 25(12):2465-2482. PubMed ID: 27154199
[TBL] [Abstract][Full Text] [Related]
29. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia.
Greco S; De Simone M; Colussi C; Zaccagnini G; Fasanaro P; Pescatori M; Cardani R; Perbellini R; Isaia E; Sale P; Meola G; Capogrossi MC; Gaetano C; Martelli F
FASEB J; 2009 Oct; 23(10):3335-46. PubMed ID: 19528256
[TBL] [Abstract][Full Text] [Related]
30. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
31. Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease.
Almada AE; Wagers AJ
Nat Rev Mol Cell Biol; 2016 May; 17(5):267-79. PubMed ID: 26956195
[TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
33. [Regenerative medicine of skeletal muscle].
Hara T; Nakayama Y; Nara N
Rinsho Shinkeigaku; 2005 Nov; 45(11):880-2. PubMed ID: 16447752
[TBL] [Abstract][Full Text] [Related]
34. MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy.
Bobadilla M; Sáinz N; Rodriguez JA; Abizanda G; Orbe J; de Martino A; García Verdugo JM; Páramo JA; Prósper F; Pérez-Ruiz A
Stem Cells; 2014 Feb; 32(2):447-61. PubMed ID: 24123596
[TBL] [Abstract][Full Text] [Related]
35. Correlated NOS-Imu and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment.
Anderson JE; Vargas C
Neuromuscul Disord; 2003 Jun; 13(5):388-96. PubMed ID: 12798794
[TBL] [Abstract][Full Text] [Related]
36. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.
Villalta SA; Nguyen HX; Deng B; Gotoh T; Tidball JG
Hum Mol Genet; 2009 Feb; 18(3):482-96. PubMed ID: 18996917
[TBL] [Abstract][Full Text] [Related]
37. Fibrosis-Inducing Strategies in Regenerating Dystrophic and Normal Skeletal Muscle.
Pessina P; Muñoz-Cánoves P
Methods Mol Biol; 2016; 1460():73-82. PubMed ID: 27492167
[TBL] [Abstract][Full Text] [Related]
38. Small Fractions of Muscular Dystrophy Embryonic Stem Cells Yield Severe Cardiac and Skeletal Muscle Defects in Adult Mouse Chimeras.
Gonzalez JP; Kyrychenko S; Kyrychenko V; Schneider JS; Granier CJ; Himelman E; Lahey KC; Zhao Q; Yehia G; Tao YX; Bhaumik M; Shirokova N; Fraidenraich D
Stem Cells; 2017 Mar; 35(3):597-610. PubMed ID: 27734557
[TBL] [Abstract][Full Text] [Related]
39. Low-Level Laser Therapy (LLLT) in Dystrophin-Deficient Muscle Cells: Effects on Regeneration Capacity, Inflammation Response and Oxidative Stress.
Macedo AB; Moraes LH; Mizobuti DS; Fogaça AR; Moraes Fdos S; Hermes Tde A; Pertille A; Minatel E
PLoS One; 2015; 10(6):e0128567. PubMed ID: 26083527
[TBL] [Abstract][Full Text] [Related]
40. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice.
Liu Y; Yan X; Sun Z; Chen B; Han Q; Li J; Zhao RC
Stem Cells Dev; 2007 Oct; 16(5):695-706. PubMed ID: 17999592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
